| mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
-0.026 |
0.9 |
| mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |